Fertility Protection for Children, Adolescents and Young Adults
Launched by UNIVERSITY OF ULM · Nov 14, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on protecting the fertility of children, adolescents, and young adults who are undergoing cancer treatments or stem cell transplants. These treatments can sometimes affect a person's ability to have children in the future, so the study aims to understand the risks involved and how to provide better support for patients and their families. Researchers will look at different factors that may predict fertility issues after treatment, listen to the concerns of young patients and their families, and find ways to improve the medical care they receive related to fertility preservation.
Eligible participants for this trial include children and young adults under 21 who have been diagnosed with cancer or are undergoing stem cell transplantation at the University Medical Center Ulm in Germany. Those who join the study can expect to share their medical information and experiences, which will help researchers understand the long-term effects of cancer treatments on fertility. The ultimate goal is to create a dedicated center that offers better fertility support and improves the overall quality of care for young cancer patients.
Gender
ALL
Eligibility criteria
- • Children, adolescents, young adults with a diagnosis of cancer before the age of 21 years
- • or
- • Children, adolescents, young adults undergoing SCT for a malignant or non-malignant condition before the age of 21 years
- • treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
About University Of Ulm
The University of Ulm is a leading academic institution located in Germany, renowned for its commitment to cutting-edge research and innovation in the fields of medicine and health sciences. As a clinical trial sponsor, the university leverages its robust network of researchers and clinical experts to advance medical knowledge and improve patient outcomes. With a focus on interdisciplinary collaboration, the University of Ulm conducts comprehensive clinical studies that adhere to the highest ethical standards and regulatory guidelines. Through its research initiatives, the university aims to contribute significantly to the development of new therapies and treatment modalities, fostering a deeper understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ulm, Baden Württemberg, Germany
Ulm, Baden Württemberg, Germany
Ulm, , Germany
Patients applied
Trial Officials
Christian Denzer, Prof. Dr.
Principal Investigator
Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes
Martin Wabitsch, Prof. Dr.
Study Chair
Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported